{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T23:52:36Z","timestamp":1648857156864},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00105-021-04815-3","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T13:06:45Z","timestamp":1619528805000},"page":"216-219","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Atypische, Myofibroblasten-reiche Keloide im Rahmen einer Acne vulgaris"],"prefix":"10.1007","volume":"73","author":[{"given":"N.","family":"Scheiba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Hartschuh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"issue":"12","key":"4815_CR1","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s00105-014-3546-0","volume":"65","author":"R Aschoff","year":"2014","unstructured":"Aschoff\u00a0R (2014) Therapie hypertropher Narben und Keloide [Therapy of hypertrophic scars and keloids]. Hautarzt 65(12):1067\u20131077","journal-title":"Hautarzt"},{"key":"4815_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/sj.cdd.4400605","volume":"7","author":"C Chipev","year":"2000","unstructured":"Chipev\u00a0C, Simman\u00a0R, Hatch\u00a0G et\u00a0al (2000) Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts\u00a0in vitro. Cell Death Differ 7:166\u2013176","journal-title":"Cell Death Differ"},{"key":"4815_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2230.1994.tb01200.x","volume":"19","author":"AM Layton","year":"1994","unstructured":"Layton\u00a0AM, Henderson\u00a0CA, Cunliffe\u00a0WJ (1994) A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol 19:303\u2013308","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"4815_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/00000372-200410000-00006","volume":"26","author":"JY Lee","year":"2004","unstructured":"Lee\u00a0JY, Yang\u00a0CC, Chao\u00a0SC, Wong\u00a0TW (2004) Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol 26(5):379\u2013384","journal-title":"Am J Dermatopathol"},{"key":"4815_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fcell.2020.00360","volume":"8","author":"GC Limandjaja","year":"2020","unstructured":"Limandjaja\u00a0GC, Niessen\u00a0FB, Scheper\u00a0RJ, Gibbs\u00a0S (2020) The keloid disorder: heterogeneity, histopathology, mechanisms and models. Front Cell Dev Biol 8:360","journal-title":"Front Cell Dev Biol"},{"key":"4815_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s002920050272","volume":"19","author":"P Meister","year":"1998","unstructured":"Meister\u00a0P (1998) Myofibroblasten \u00dcbersicht und Ausblick. Pathologe 19:187\u2013193","journal-title":"Pathologe"},{"key":"4815_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ajcp\/107.1.2","volume":"107","author":"T Mentzel","year":"1997","unstructured":"Mentzel\u00a0T, Fletcher\u00a0CDM (1997) The emerging role of myofibroblasts in soft tissue neoplasia. Am J Clin Pathol 107:2\u20135","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"4815_CR8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/ddg.14279","volume":"19","author":"A Nast","year":"2020","unstructured":"Nast\u00a0A et al (2020) S2k-Leitlinie Therapie pathologischer Narben (hypertrophe Narben und Keloide)\u00a0\u2013 Update 2020. J\u00a0Dtsch Dermatol Ges 19(2):312\u2013327. https:\/\/doi.org\/10.1111\/ddg.14279","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"5","key":"4815_CR9","first-page":"467","volume":"14","author":"J Poetschke","year":"2016","unstructured":"Poetschke\u00a0J, Gauglitz\u00a0GG (2016) Current options for the treatment of pathological scarring. J\u00a0Dtsch Dermatol Ges 14(5):467\u2013477","journal-title":"J. Dtsch. Dermatol. Ges."},{"issue":"12","key":"4815_CR10","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/j.1346-8138.1997.tb02329.x","volume":"24","author":"M Tani","year":"1997","unstructured":"Tani\u00a0M, Komura\u00a0A, Ichihashi\u00a0M (1997) Dermatomyofibroma (Plaquef\u00f6rmige Dermale Fibromatose). J\u00a0Dermatol 24(12):793\u2013797","journal-title":"J Dermatol"},{"issue":"2","key":"4815_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1524-4725.2008.34406.x","volume":"35","author":"D Wolfram","year":"2009","unstructured":"Wolfram\u00a0D, Tzankov\u00a0A, P\u00fclzl\u00a0P, Piza-Katzer\u00a0H (2009) Hypertrophic scars and keloids\u2014a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 35(2):171\u2013181","journal-title":"Dermatol Surg"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04815-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-021-04815-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04815-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T14:03:12Z","timestamp":1646143392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-021-04815-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["4815"],"URL":"https:\/\/doi.org\/10.1007\/s00105-021-04815-3","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,27]]},"assertion":[{"value":"24 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"N.\u00a0Scheiba und W.\u00a0Hartschuh geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}